133 related articles for article (PubMed ID: 10872037)
1. Real-time quantification of the proliferative state in astrocytomas.
Ricco R; Cimmino A; Renzulli G; Serio G; Lozupone A; Lettini T; Pece A; Giardina C; Delfino VP
Anal Quant Cytol Histol; 2000 Jun; 22(3):213-7. PubMed ID: 10872037
[TBL] [Abstract][Full Text] [Related]
2. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
4. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
5. Proliferative index in astrocytic tumours.
Rathi KR; Radotra BD; Khosla VK
Indian J Pathol Microbiol; 2007 Oct; 50(4):754-8. PubMed ID: 18306542
[TBL] [Abstract][Full Text] [Related]
6. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
Thotakura M; Tirumalasetti N; Krishna R
J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
[TBL] [Abstract][Full Text] [Related]
7. Cellular proliferation in pilocytic and diffuse astrocytomas.
Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
[TBL] [Abstract][Full Text] [Related]
8. Computer-assisted discrimination of glioblastomas.
Scarpelli M; Montironi R; Thompson D; Bartels PH
Anal Quant Cytol Histol; 1997 Oct; 19(5):369-75. PubMed ID: 9349896
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas.
Eneström S; Vavruch L; Frånlund B; Nordenskjöld B
Neurochirurgie; 1998 Mar; 44(1):25-30. PubMed ID: 9757314
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
[TBL] [Abstract][Full Text] [Related]
11. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors.
Khalid H; Shibata S; Kishikawa M; Yasunaga A; Iseki M; Hiura T
Cancer; 1997 Dec; 80(11):2133-40. PubMed ID: 9392336
[TBL] [Abstract][Full Text] [Related]
14. A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
Sharma S; Karak AK; Singh R; Mehta VS; Sarkar C; Schmitt HP
Pathol Oncol Res; 1999; 5(2):134-41. PubMed ID: 10393366
[TBL] [Abstract][Full Text] [Related]
15. Correlation of TGF-alpha and EGF-receptor expression with proliferative activity in human astrocytic gliomas.
von Bossanyi P; Sallaba J; Dietzmann K; Warich-Kirches M; Kirches E
Pathol Res Pract; 1998; 194(3):141-7. PubMed ID: 9587931
[TBL] [Abstract][Full Text] [Related]
16. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
Haapasalo J; Mennander A; Helen P; Haapasalo H; Isola J
J Clin Pathol; 2005 Mar; 58(3):263-8. PubMed ID: 15735157
[TBL] [Abstract][Full Text] [Related]
17. Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes.
Sallinen PK; Sallinen SL; Helén PT; Rantala IS; Rautiainen E; Helin HJ; Kalimo H; Haapasalo HK
Neuropathol Appl Neurobiol; 2000 Aug; 26(4):319-31. PubMed ID: 10931365
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
Kordek R; Biernat W; Alwasiak J; Liberski PP
Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
[TBL] [Abstract][Full Text] [Related]
19. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
[TBL] [Abstract][Full Text] [Related]
20. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
